Peptide TherapeuticsPeer Reviewed

Disseminated Mycobacterium haemophilum Infection after Antitumor Necrosis Factor Therapy, Misdiagnosed as Leprosy.

Authors (4)
Alireza Eskandari
Mitra Rezaei
Afshin MoniriClinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Majid MarjaniClinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
International journal of mycobacteriology
Unknown
Published
Oct 13, 2025
View Original

Abstract

Mycobacterium haemophilum is a nontuberculous mycobacterium that predominantly causes disease in immunocompromised patients. Due to some similarities, especially in terms of skin manifestations to Mycobacterium leprae, disease caused by these two agents may be commonly confused with each other. Here, we describe an immunocompromised adult patient with disseminated skin lesions, prolonged cough, and progressive ocular symptoms with the initial diagnosis of leprosy but a final diagnosis of M. haemophilum infection. Clinical clues such as the pattern of skin lesions, detailed neurological examination, and concurrent involvement of other organs, combined with molecular techniques could eventually lead to the correct diagnosis.

Keywords

Haemophilumimmunosuppressive drugsleprosymycobacteriumnontuberculous mycobacteria

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics